Quick Answer
Vivani Medical, Inc. reported Cash and Equivalents of $16.23 million for fiscal year 2025.
Vivani Medical, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $16.23M | -11.6% |
| 2024 | $18.35M | -11.1% |
| 2023 | $20.65M | -54.2% |
| 2022 | $45.08M | -35.2% |
| 2021 | $69.59M | +2090.5% |
| 2020 | $3.18M | -72.0% |
| 2019 | $11.33M | +153.3% |
| 2018 | $4.47M | -43.0% |
| 2017 | $7.84M | -27.9% |
| 2016 | $10.88M | -31.9% |
| 2015 | $15.96M | +2478.4% |
| 2014 | $619.0K | +898.4% |
| 2013 | $62.0K | -57.2% |
| 2012 | $145.0K | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.63M | -86.6% | -61.3% |
| June 30, 2025 | $6.79M | -72.7% | -47.8% |
| March 31, 2025 | $13.01M | -56.1% | -29.1% |
| December 31, 2024 | $18.35M | -11.1% | -6.6% |
| September 30, 2024 | $19.65M | -20.8% | -21.2% |
| June 30, 2024 | $24.92M | -23.3% | -16.0% |
| March 31, 2024 | $29.65M | -22.1% | +43.5% |
| December 31, 2023 | $20.65M | -54.2% | -16.8% |
- Vivani Medical, Inc. showed a decrease of -11.6% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2012–2025 period, Vivani Medical, Inc.’s cash and equivalents has grown by 11094.5% (from $145.0 thousand to $16.23 million).
- The most recent figure is from Vivani Medical, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: